Ahngook Pharm’s osteoporosis treatment, ‘Binosto Effervescent Tab’ to be approved
Ahngook Pharm(President Uh Jin) has completed domestic approval of Binosto Effervescent Tab(alendronate sodium 70mg), a bisphosphonate-type osteoporosis treatment, on Oct. 14.
Binosto Effervescent Tab is a novel improved drug in an effervescent type which was first developed by EffRx Pharmaceuti...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
